Nashville, TN, United States of America

Melissa A Korkmaz-Vaisys

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Vanderbilt University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Melissa A Korkmaz-Vaisys. Retrieved from https://idiyas.com/inventor/melissa-a-korkmaz-vaisys

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Melissa A Korkmaz-Vaisys: Innovator in Neurodegenerative Disorder Treatments

Introduction

Melissa A Korkmaz-Vaisys is an accomplished inventor based in Nashville, TN (US). She is affiliated with Vanderbilt University, where she contributes to research focused on neurodegenerative disorders. Despite having no granted patents to her name, her work in the field is noteworthy.

Latest Patent Applications

Melissa's latest patent applications include significant advancements in the treatment of neurodegenerative disorders. One application, titled "Antagonists of the Muscarinic Acetylcholine Receptor M4," discloses various compounds that serve as antagonists of the muscarinic acetylcholine receptor M4. These compounds are useful in treating disorders such as Parkinson's disease, schizophrenia, and attention deficit hyperactivity disorder (ADHD). Another application focuses on derivatives that act as M4 antagonists for the treatment of various brain disorders, highlighting her innovative approach to addressing complex medical challenges.

Conclusion

Melissa A Korkmaz-Vaisys is a dedicated inventor whose research aims to improve treatments for neurodegenerative disorders. Her contributions to the field, particularly through her latest patent applications, showcase her commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…